The integration of Accu-Chek SmartGuide's AI-enabled predictive CGM with the popular mySugr app delivers a simple, intuitive solution for people to manage their diabetes with greater ease. Accu-Chek ...
The Insight will live on as an electric crossover SUV. Honda is opening orders in Japan on Friday, starting at about $35,000, but the new EV will be extremely limited. Honda Insight EV orders open in ...
First diabetes data management platform outside of Rocheās ecosystem to integrate with Accu-Chek SmartGuide CGM, bringing more choice and a more complete view of data to people with diabetes and their ...
Launched in 1999, the first-generation Insight was Hondaās first mass-produced hybrid vehicle. Since then, the 2-seat hatchback evolved into a 5-seater and, in its third generation, into a 4-door ...
View post: Toyota Land Cruiser FJ Is A $28,500 Off-Roader America Still Canāt Buy 2027 Honda Insight revealed for Japan as all-electric crossover. New Insight EV offers 311-mile WLTC range, ...
Honda is reviving the Insight name, but the familiar hybrid sedan isnāt coming back. This time, itās an electric coupe crossover with Chinese roots. Honda is reviving the Insight name as a fully ...
Roche Diagnostics Middle East presented a landmark launch event revealing Accu-Chek SmartGuide, a breakthrough Continuous Glucose Monitoring (CGM) innovation that sets a new standard of care for ...
Roche has announced that its Accu-Chek® SmartGuide continuous glucose monitoring (CGM) solution is now available in South Africa. This significant milestone means that people living with diabetes over ...
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that its Accu-Chek® SmartGuide continuous glucose monitoring (CGM) solution is now available in South Africa. This significant milestone means that ...
For someone living with diabetes, blood sugar can change throughout the day. These changes might occur after a large meal, an unexpected delay in medication, a brisk walk, or even a stressful work ...
BASEL, Switzerland, Sept. 16, 2025 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) shared real-world evidence from the rollout of Accu-Chek SmartGuide continuous glucose monitoring (CGM) solution ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results